| Christina Charles-beery, MD | |
|
750 Mount Carmel Mall, Ste 110, Columbus, OH 43222-1576 | |
| (614) 434-2400 | |
| (614) 434-2499 |
| Full Name | Christina Charles-beery |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 25 Years |
| Location | 750 Mount Carmel Mall, Columbus, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073512034 | NPI | - | NPPES |
| 2418299 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35081880C (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverside Methodist Hospital | Columbus, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Columbus Obstetricians - Gynecologists, Inc. | 5597666453 | 22 |
News Archive
Metal-on-metal resurfacing for osteoarthritis should be used only in men with a large femoral head, UK researchers believe.
Lauren Strober, PhD, at Kessler Foundation recently published results of the first prospective study of employment and multiple sclerosis (MS).
Many people admitted to hospitals in the U.S. have alcohol use disorders that go undetected, according to a new study by scientists at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), one of the National Institutes of Health (NIH).
The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years. On March 9, 2010, an FDA Advisory Committee recommended approval of the drug by the FDA.
› Verified 6 days ago
| Entity Name | Columbus Obstetricians - Gynecologists, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407855323 PECOS PAC ID: 5597666453 Enrollment ID: O20040220000003 |
News Archive
Metal-on-metal resurfacing for osteoarthritis should be used only in men with a large femoral head, UK researchers believe.
Lauren Strober, PhD, at Kessler Foundation recently published results of the first prospective study of employment and multiple sclerosis (MS).
Many people admitted to hospitals in the U.S. have alcohol use disorders that go undetected, according to a new study by scientists at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), one of the National Institutes of Health (NIH).
The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years. On March 9, 2010, an FDA Advisory Committee recommended approval of the drug by the FDA.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christina Charles-beery, MD 750 Mount Carmel Mall, Ste 110, Columbus, OH 43222-1576 Ph: (614) 434-2400 | Christina Charles-beery, MD 750 Mount Carmel Mall, Ste 110, Columbus, OH 43222-1576 Ph: (614) 434-2400 |
News Archive
Metal-on-metal resurfacing for osteoarthritis should be used only in men with a large femoral head, UK researchers believe.
Lauren Strober, PhD, at Kessler Foundation recently published results of the first prospective study of employment and multiple sclerosis (MS).
Many people admitted to hospitals in the U.S. have alcohol use disorders that go undetected, according to a new study by scientists at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), one of the National Institutes of Health (NIH).
The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years. On March 9, 2010, an FDA Advisory Committee recommended approval of the drug by the FDA.
› Verified 6 days ago
Dr. Robert Brigden Halpin, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3535 Olentangy River Rd, Columbus, OH 43214 Phone: 614-566-4378 Fax: 614-566-6904 | |
Dr. Brenna Espelien, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 410 W 10th Ave, Columbus, OH 43210 Phone: 614-293-8045 | |
Nidhi Goel, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 410 W 10th Ave, Columbus, OH 43210 Phone: 614-293-8045 | |
Jay Donald Iams, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1800 Zollinger Rd, 4th Floor, Columbus, OH 43221 Phone: 614-293-2222 Fax: 614-293-2200 | |
Julie M Jones, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 750 Mount Carmel Mall, Suite 100, Columbus, OH 43222 Phone: 614-434-2400 Fax: 614-434-2499 | |
Dorothy A Friday, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 750 Mount Carmel Mall, Suite 100, Columbus, OH 43222 Phone: 614-434-2400 Fax: 614-434-2499 | |
Melissa M Goist, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2020 Kenny Rd, Columbus, OH 43221 Phone: 614-293-3069 Fax: 614-293-9684 |